EFTA01373763.pdf
👁 1
💬 0
📄 Extracted Text (303 words)
From: Wayne Salit
Sent: 1/21/2016 10:30:17 AM
To: Daniel Sabba
CC: Mark Frankel Martin Cunningham Todd Stevens
Chip Packard
Subject: FW: Jeffrey Epstein/Southern Financial LLC - Rep Risk Approval ICI Ill
Classification: For Internal use only
Dan -
You should reach out to Mark Frankel for an updated External Due Diligence ("Level II") Report. He can guide you
through the process.
Kind Regards,
Wayne Salit
Deutsche Bank Americas
(212) 250-2285 (ph)
From: Carol Saracco
Sent: Thursday, January 21, 2016 9:31 AM
To: Daniel Sabba
Cc: Wayne Salit; Todd Stevens; Chip Packard
Subject: RE: Jeffrey Epstein/Southern Financial LLC - Rep Risk Approval [C] [I]
Classification: For Internal use only
Wayne
The committee wants an updated due diligence report. Can you order a level 2 kroll report? (I think it is level 2). Thx
From: Daniel Sabba
Sent: Wednesday, January 20, 2016 2:57 PM
To: Carol Saracco
Cc: Wayne Salit; Todd Stevens; Chip Packard
Subject: FW: Jeffrey Epstein/Southern Financial LLC - Rep Risk Approval [C] [I]
Hi Carol — Wayne Salit suggested we reach out to you. Jeffrey Epstein has requested the opening of a new DBSI account
for one of his entities (Gratitude America, Ltd.). We have reached out to Wayne to clarify whether this can be done with
the approvals we have in place or whether this has to be brought to the RRC. Wayne deferred the question to you - the
email below has the specific guidance received from Jan Ford. Can you please advise if possible. Thank you, Daniel
From: Wayne Salit
Sent: Tuesday, January 19, 2016 2:10 PM
To: Daniel Sabba
Cc: Todd Stevens; Chip Packard; Jan Bornebusch
Subject: RE: Jeffrey Epstein/Southern Financial LLC - Rep Risk Approval [C] [I]
Classification: For internal use only
Dan -
CONFIDENTIAL - PURSUANT TO FED. R. GRIM. P. 6(e) DB-SDNY-0068118
CONFIDENTIAL SDNY_GM_00214302
EFTA01373763
ℹ️ Document Details
SHA-256
6fc9fb6e92dc94e9c93bf41a9b57a42a16ef1279a8c7cd2af95e2c6238ca4ac6
Bates Number
EFTA01373763
Dataset
DataSet-10
Type
document
Pages
1
💬 Comments 0